Research map: Dissociation and antidepressant response to subcutaneous esketamine: A clinical study

Back to the article

Papers in this map

  1. A New Depression Scale Designed to be Sensitive to Change · Stuart Montgomery · 1979 · 14136 citations · Cited by this paper
  2. Psychiatric or psychological treatment of depression in older adults and subsequent risk of dementia: Health and Retirement Study2012-2020 · 2026 · Related
  3. Antidepressant effects of ketamine in depressed patients · Robert Berman · 2000 · 3906 citations · Cited by this paper
  4. Balancing burden and resolution: Effects of EMA survey schedule on compliance and study evaluation in suicide-focused research · 2026 · Related
  5. Repeated Measures Correlation · Jonathan Z. Bakdash · 2017 · 2119 citations · Cited by this paper
  6. Emotional dysfunction as a predictor of reported current, but not childhood, ADHD symptoms among adults with and without ADHD · 2026 · Related
  7. Psychedelics · David E. Nichols · 2016 · 1808 citations · Cited by this paper
  8. The mental health-cannabis nexus: Patterns of use among U.S. adults with depression, anxiety, and ADHD · 2026 · Related
  9. Rapid and Longer-Term Antidepressant Effects of Repeated Ketamine Infusions in Treatment-Resistant Major Depression · James W. Murrough · 2012 · 792 citations · Cited by this paper
  10. Autism-like features in individuals at clinical high risk for psychosis: a longitudinal research using the PANSS Autism Severity Score (PAUSS) · 2026 · Related
  11. Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation · Roger S. McIntyre · 2021 · 724 citations · Cited by this paper
  12. Guided tapering of antipsychotics in patients with Schizophrenia: Relapse-status and cognition · 2026 · Related
  13. Psychedelics and Psychedelic-Assisted Psychotherapy · Collin M. Reiff · 2020 · 654 citations · Cited by this paper
  14. Network intervention analysis of a school-based gaming disorder prevention program in Hong Kong primary school students · 2026 · Related
  15. Set and setting, psychedelics and the placebo response: An extra-pharmacological perspective on psychopharmacology · Ido Hartogsohn · 2016 · 487 citations · Cited by this paper
  16. Intrinsic reward sensitivity drives internet gaming disorder through striatal-thalamic hyper-synchronization · 2026 · Related
  17. Intravenous Esketamine in Adult Treatment-Resistant Depression: A Double-Blind, Double-Randomization, Placebo-Controlled Study · Jaskaran B. Singh · 2015 · 472 citations · Cited by this paper
  18. Assessment of glymphatic system function in young major depressive disorder using multimodal MRI · 2026 · Related
  19. Do the dissociative side effects of ketamine mediate its antidepressant effects? · David A. Luckenbaugh · 2014 · 287 citations · Cited by this paper
  20. Prevalence and associated factors of postpartum depression at 5–8 weeks postpartum in a developed district of South China: a retrospective cross-sectional study · 2026 · Related
  21. Placebo‐controlled pilot trial testing dose titration and intravenous, intramuscular and subcutaneous routes for ketamine in depression · Colleen K A Loo · 2016 · 259 citations · Cited by this paper
  22. Intravenous arketamine for treatment-resistant depression: open-label pilot study · Gustavo Carneiro-Gomes Leal · 2020 · 259 citations · Cited by this paper
  23. Molecular mechanisms of the rapid-acting and long-lasting antidepressant actions of (R)-ketamine · Kenji Hashimoto · 2020 · 238 citations · Cited by this paper
  24. The antidepressant effect of ketamine is not associated with changes in occipital amino acid neurotransmitter content as measured by [1H]-MRS · Gerald W. Valentine · 2011 · 205 citations · Cited by this paper
  25. Efficacy and safety of adjunctive therapy using esketamine or racemic ketamine for adult treatment-resistant depression: A randomized, double-blind, non-inferiority study · Fernanda S. Correia‐Melo · 2019 · 194 citations · Cited by this paper
  26. Rapid and longer-term antidepressant effects of repeated-dose intravenous ketamine for patients with unipolar and bipolar depression · Wei Zheng · 2018 · 182 citations · Cited by this paper
  27. Psychedelic-Assisted Psychotherapy—A Systematic Review of Associated Psychological Interventions · Mauro Cavarra · 2022 · 170 citations · Cited by this paper
  28. Features of dissociation differentially predict antidepressant response to ketamine in treatment-resistant depression · Mark J. Niciu · 2018 · 138 citations · Cited by this paper
  29. Treatment‐resistant major depressive disorder: Canadian expert consensus on definition and assessment · Yuri E. Rybak · 2021 · 98 citations · Cited by this paper
  30. The relationship between subjective effects induced by a single dose of ketamine and treatment response in patients with major depressive disorder: A systematic review · David S. Mathai · 2019 · 97 citations · Cited by this paper
  31. D-serine plasma concentration is a potential biomarker of (R,S)-ketamine antidepressant response in subjects with treatment-resistant depression · Ruin Moaddel · 2014 · 86 citations · Cited by this paper
  32. Esketamine: A Novel Option for Treatment-Resistant Depression · Kevin M. Bozymski · 2019 · 84 citations · Cited by this paper
  33. The interplay of cannabinoid and NMDA glutamate receptor systems in humans: Preliminary evidence of interactive effects of cannabidiol and ketamine in healthy human subjects · Jaime E. C. Hallak · 2010 · 83 citations · Cited by this paper
  34. Population Pharmacokinetics of Esketamine Nasal Spray and its Metabolite Noresketamine in Healthy Subjects and Patients with Treatment-Resistant Depression · Carlos Pérez‐Ruixo · 2020 · 82 citations · Cited by this paper
  35. Symptomatology and predictors of antidepressant efficacy in extended responders to a single ketamine infusion · Steven J. Pennybaker · 2016 · 77 citations · Cited by this paper
  36. Acute psychoactive effects of intravenous ketamine during treatment of mood disorders: Analysis of the Clinician Administered Dissociative State Scale · Gerrit Ian van Schalkwyk · 2017 · 77 citations · Cited by this paper
  37. Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trial · Colleen K A Loo · 2023 · 77 citations · Cited by this paper
  38. The Use of Ketamine in Psychiatry · E. Khorramzadeh · 1973 · 71 citations · Cited by this paper
  39. A qualitative and quantitative account of patient’s experiences of ketamine and its antidepressant properties · Rachael L. Sumner · 2021 · 71 citations · Cited by this paper

Source: OpenAlex (CC0)